Invivoscribe Begins Commercial Shipments of PrepQuant™ Systems, Enabling High-Sensitivity Sample Preparation for MRD Testing
New automated platform is designed to improve the quality, efficiency, and consistency of DNA extraction and concentration from large-volume blood and plasma samples, supporting downstream assays capable of detecting disease-associated signals at MRD sensitivity levels. SAN DIEGO — Invivoscribe®, a global leader in precision diagnostics and measurable residual disease (MRD) testing, today…
We haven't written up this one. Financial Post has the full story — the link below goes straight to it.
